Inhaled treprostinil for treating pulmonary hypertension with interstitial lung disease [ID6459]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: 25 February 2026
Sotatercept for treating pulmonary arterial hypertension [ID6163]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC